Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: This is a spontaneous report from a contactable consumer received from the Regulatory Agency. A 37-year-old female patient received bnt162b2, via unspecified route of administration on 03Jun2021 (batch/lot number and expiry date unknown) at 37 years of age as 1st dose, single for covid-19 immunization. Medical history included suppressed lactation, anxiety. Concomitant medications included sertraline taken for anxiety from 01Jul2018 to an unspecified stop date. On 03Jun2021, the patient experienced painful arm, "aching deep pain around injection site" (vaccination site erythema), aching deep pain around injection site. The patient informed that she experienced aching deep pain around injection site, spread through arm from wrist to neck during the following few hours. 24 hours after injection ache reducing and more localized. The events were reported serious as other medically important condition. The patient underwent lab tests and procedures which included COVID-19 virus test: no - negative covid-19 test on unspecified date. The patient has not tested positive for COVID-19 since having the vaccine. The outcome of the events was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166